Medplus’ subsidiary, Optival Health Solutions, received six suspension orders for drug licenses, effective from March 22, 2025, across various locations, resulting in a potential revenue loss of approximately Rs 10.55 lakhs.
AI Assistant
Medplus Health Services Ltd
2025
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.